Houston Methodist Neal Cancer Center

Houston, Texas 77030

10 studies enrolling now · 11 studies all time

What they study most

Acute Myeloid Leukaemia (AML), Acute Myeloid Leukemia (AML), Bladder Cancer, Brain Cancer Metastatic, CMV Viremia, Cancer, Carcinoma, Non-Small-Cell Lung, Chemotherapy-induced Peripheral Neuropathy, HER2-negative Breast Cancer, Hepatocellular Carcinoma, Hepatopancreaticobiliary (HPB) Malignancy, Kidney Cancers

Studies at this site

• Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection — Recruiting now
• Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC) — Recruiting now
• Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer — Recruiting now
• Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer — Recruiting now
• ATRA and Carfilzomib in Plasma Cell Myeloma Patients — Recruiting now
• Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery — Recruiting now
• Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies — Recruiting now
• Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA) — Recruiting now
• 5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer — Recruiting now
• Trial to Study Electro-Acupuncture in Subjects With Chemotherapy-Induced Peripheral Neuropathy — Completed
• Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker — Starting soon